Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells

  • Li-Han Chin,
  • Sung-Po Hsu,
  • Wen-Bin Zhong,
  • Yu-Chih Liang

There is an error in affiliation 2 for authors Sung-Po Hsu and Wen-Bin Zhong. Affiliation 2 should be: Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Reference

  1. 1. Chin L-H, Hsu S-P, Zhong W-B, Liang Y-C (2015) Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells. PLoS ONE 10(3): e0118674. https://doi.org/10.1371/journal.pone.0118674 pmid:25742642

Citation: Chin L-H, Hsu S-P, Zhong W-B, Liang Y-C (2017) Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells. PLoS ONE 12(5): e0177545. https://doi.org/10.1371/journal.pone.0177545

Published: May 8, 2017

Copyright: © 2017 Chin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.